INTERNATIONAL CANCER INSTITUTE PROSTATE CANCER PRECEPTORSHIP
Starting on:
Aug 11, 2020
Ending on:
Jul 10, 2020
Moderator(s):
Venue:
Virtual- International Cancer Institute
Max Credits:
5 Points

Provider:
International Cancer Institute
Claim Points

INTERNATIONAL CANCER INSTITUTE PROSTATE CANCER PRECEPTORSHIP

Starting on:
Aug 11, 2020 4:00 PM
Ending on:
Jul 10, 2020 5:30 PM
Venue:
Virtual- International Cancer Institute

Description

Multidisciplinary management, standards of care, optimal diagnostics, therapies and future perspectives in the care of Prostate Cancer patients in sub-Saharan Africa.

Objectives

At the end of this educational activity, participants should be able to: 1. Understand the Epidemiology of Prostate Cancer (Global) 2. To understand the role of screening for prostate cancer, including the evidence for and against the use of prostate-specific antigen (PSA) screening and the practical indications of serum PSA measurement in different clinical settings 3. recognize the role of pathological diagnosis, histologic grading, Gleason system, staging and prognostic factors in prostate cancer. 4. To understand the role of Surgery in the management of localized prostate cancer 5. To understand the role of radiotherapy in the management of localized prostate cancer 6. understand the management options for hormone sensitive metastatic prostate cancer 7. To understand the definition of castration-resistant prostate cancer (CRPC) and appreciate the novel therapies, their use and side effects profile in m-CRPC. 8. Discuss treatment options for patients with advanced prostate cancer, including secondary hormonal therapy, chemotherapy, immunotherapy, and radioisotope therapy 9. Understanding of how and when to use bone-targeted therapies and of the prevention and treatment of osteonecrosis of the jaw 10. To understand the role of multidisciplinary team in prostate cancer management 11. To understand the role of Palliative, supportive and survivorship care in prostate cancer management 12. Ability to diagnose and manage spinal cord compression, one of the most devastating complications of metastatic prostate cancer 13. To discuss clinical cases between faculty and participants

Presenters

  1. Prof. Chite Asirwa
    Consultant Physician, Medical Oncologist & Hematologst Executive Director/CEO: Inernational Cancer Institute
    ICI

  2. Prof. Dinesh Pendharkar
    Consultant Oncologist

  3. Dr. Kibet Keitany
    Anatomic Pathologist

  4. Dr. Verna Vanderpuye
    Consultant Radiation Oncologist

  5. Dr. Helena Musau
    Clinical Oncologist
    Meru County Referral Hospital

  6. Dr. Abdu Yesufe
    Clinical Oncologist

  7. Dr. Irene Weru
    Oncology Pharmacist

  8. Dr. Sitna Mwanzi
    Medical Oncologist

  9. Dr. Achille Manirakiza
    Clinical Oncologist

  10. Dr. Zipporah Ali
    Palliative Care Specialist

Search For CPD Activity